Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low Risk Prostate Cancer”

256 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 256 results

Testing effectiveness (Phase 2)Ended earlyNCT02648919
What this trial is testing

Clinical Study of Noni Extract in Men With Very Low Risk or Low Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Hawaii 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07224009
What this trial is testing

Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)

Who this might be right for
Metastatic Prostate Cancer
University of Arkansas 60
Not applicableWithdrawnNCT00963300
What this trial is testing

MRI in Assessing Hypoxia in Patients With Localized Prostate Cancer Undergoing Stereotactic Body Radiation Therapy

Who this might be right for
Prostate Cancer
University of Texas Southwestern Medical Center
Not applicableLooking for participantsNCT06027892
What this trial is testing

Two-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate Cancer

Who this might be right for
PROSTATE CANCER
Rabin Medical Center 562
Testing effectiveness (Phase 2)Study completedNCT01620515
What this trial is testing

Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancer

Who this might be right for
Prostate Cancer
Nymox Corporation 141
Not applicableStudy completedNCT01664130
What this trial is testing

High-Dose Stereotactic Radiation for Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more
Case Comprehensive Cancer Center 35
Not applicableEnded earlyNCT00773318
What this trial is testing

SPECT-CT Guided Lymphatic Mapping and Sentinel Lymphadenectomy (LM/SL) in Prostate Cancer

Who this might be right for
Prostate Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 30
Testing effectiveness (Phase 2)Study completedNCT00895310
What this trial is testing

Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy

Who this might be right for
Prostate Cancer
University of California, Davis 30
Not applicableNot Yet RecruitingNCT06718647
What this trial is testing

Efficacy and Tolerability of Low-Dose Enzalutamide in Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic Disease
Monica Boitano 150
Not applicableStudy completedNCT00897793
What this trial is testing

Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+2 more
Vanderbilt-Ingram Cancer Center 25
Large-scale testing (Phase 3)UnknownNCT01354171
What this trial is testing

Active Surveillance Magnetic Resonance Imaging Study

Who this might be right for
Prostate Cancer
Canadian Urology Research Consortium 250
Testing effectiveness (Phase 2)Study completedNCT02353832
What this trial is testing

Stereotactic Ablative Radiotherapy (SABR) for Low Risk Prostate Cancer With Injectable Rectal Spacer

Who this might be right for
Prostate Cancer
University of Texas Southwestern Medical Center 44
Testing effectiveness (Phase 2)WithdrawnNCT01859689
What this trial is testing

Internal Radiation Therapy in Treating Patients With Low-Risk Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+2 more
Jonsson Comprehensive Cancer Center
Not applicableActive Not RecruitingNCT02960087
What this trial is testing

Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

Who this might be right for
Prostate Carcinoma
Canadian Cancer Trials Group 334
Early research (Phase 1)Study completedNCT02390063
What this trial is testing

Vaccination in Prostate Cancer (VANCE)

Who this might be right for
Prostate Cancer
University of Oxford 40
Testing effectiveness (Phase 2)Ended earlyNCT01650350
What this trial is testing

Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer

Who this might be right for
MelanomaProstate CancerRenal Cancer
Brown University 7
Testing effectiveness (Phase 2)Study completedNCT00040586
What this trial is testing

Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2

Who this might be right for
Prostatic Neoplasms
BZL Biologics
Not applicableStudy completedNCT01780701
What this trial is testing

Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 66
Not applicableLooking for participantsNCT02865330
What this trial is testing

Spanish Urological Association Registry of Patients on Active Surveillance

Who this might be right for
Prostate Cancer
Fundación Instituto Valenciano de Oncología 946
Large-scale testing (Phase 3)Study completedNCT00925600
What this trial is testing

Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss

Who this might be right for
CancerCataractLow Bone Mineral Density+3 more
Amgen 769
Load More Results